Abstract
A series of novel N-methylpicolinamide-moiety containing diarylthiosemicarbazide derivatives was prepared and evaluated for their in vitro antiproliferative activity against three cancer cell lines(human alveolar epithelial cell A549, human lung cancer cell H460 and human colorectal cancer cell HT-29) by 3-(4,5-dimethyl)thiazolyl-diphenyltetrazoliumromide(MTT) assay. Six compounds(7b–7g) with halogen substituents exhibited preferable cytotoxicity against one or more cell lines in a low micromolar range. Especially, the most promising compound 7g exhibited remarkable antiproliferative activity with the IC50 values of 2.2, 1.8 and 5.2 μmol/L against A549, H460 and HT-29 cell lines respectively, which is comparable to sorafenib.
Similar content being viewed by others
References
Zhai X., Zhang C. L., He L., Li Q., Wang J. L. Shen X. L., Gong P., Chem. Res. Chinese Universities, 2009, 25(4), 474
Jiang N., Zhai X., Chen Z. C., Liang C., Sun C., Gong P., Chem. Pharm. Bull., 2012, 60, 659
Guo S. C., Zhao Y. F., Li R. D., Xie L. J., Yang Y. B., Gong P., Chem. Res. Chinese Universities, 2008, 24(1), 47
Richard M., J. Med. Chem., 2010, 53, 1413
Liu L., Cao Y., Zhang X., McNabola A., Wilkie D., Wilhelm S., Lynch M., Carter C., Cancer Res., 2006, 66, 11851
Yao P., Xue H., Liu Q., Liu H. T., Chen M. J., Gong P., Chem. Res. Chinese Universities, 2010, 26(4), 558
Yao P., Zhai X., Liu D., Qi B. H., Tan H. L., Jin Y. C., Gong P., Arch. Pharm., 2008, 343, 17
Potashman M. H., Bready J., Coxon A., Demelfi T., Dipietro L., Doerr N., Elbaum D., Estrada J., Gallant P., Germain J., Gu Y., Harmange J., Kaufman S., Kendall R., Kim J., Kumar G., Long A., Neervannan S., Patel V., Polverino A., Rose P., Plas S., Whittington D., Zanon R., Zhao H., J. Med. Chem., 2007, 50, 4351
Ramurthy S., Subramanian S., Aikawa M., Amiri P., Costales A., J. Med. Chem., 2008, 51, 7049
Dai Y., Hartandi K., Ji Z., Ji Z., Ahmed A., Albert D., Bauch J., Bouska J., Bousquet P., Cunha G., Glaser K., Harris C., Hickman D., Guo J., Li J., Marcotte P., Marsh K., Moskey M., Martin R., Olson A., Osterling D., Pease L., Soni N., Stewart K., Stoll V., Tapang P., Reuter D., Davidsen S., Michaelides M., J. Med. Chem., 2007, 50, 1584
Li W. Zhai X. Zhong Z., Li G., Pu Y., Gong P., Arch. Pharm., 2011, 344, 349
Bankston D., Dumas J., Natero R., Riedl B., Monahan M., Sibley R., Org. Process Res. Dev., 2002, 6, 777
Sonawane N., Verkman A., Bioorg. Med. Chem., 2008, 16, 8187
Khanfar M., Hill R., Kaddoumi A., Kaddoumi A., Sayed K., J. Med. Chem., 2011, 53, 8534
Ragab F., Sayed N., Eissa A., Kerdawy A., Chem. Pharm. Bull., 2010, 58, 1148
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China(No.21002065) and the Science & Technology Project of Liaoning Province, China(No.LJQ201107).
Rights and permissions
About this article
Cite this article
Zhai, X., He, Y., Yang, Z. et al. Syntheses and antiproliferative activities of novel diarylthiosemicarbazide derivatives. Chem. Res. Chin. Univ. 29, 62–66 (2013). https://doi.org/10.1007/s40242-013-2136-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-013-2136-5